Clincosm LogoSign in Get a demo

neuroendocrine tumors

Showing 51 - 75 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Subjects Previously Enrolled on NCI Surgery Branch Studies

Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

    Not yet recruiting
    • Stage I Testicular Seminoma
    • +13 more
    • Oncological Follow-up
    • Amiens, France
    • +2 more
    Aug 12, 2022

    Neuroendocrine Tumors Trial in Worldwide (Data collection)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Data collection
    • Melbourne, Australia
    • +6 more
    Aug 11, 2022

    Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

    Recruiting
    • Neuroendocrine Tumor Grade 2
    • Neuroendocrine Tumors
    • Capecitabine Oral Product
    • +2 more
    • Little Rock, Arkansas
    • +2 more
    Aug 11, 2022

    Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)

    Recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Angers, France
    • +21 more
    Aug 2, 2022

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

    Recruiting
    • Neuroendocrine Tumors
    • Gallium-68 NODAGA-JR11
    • Beijing, Beijing, China
    • +1 more
    Jul 27, 2022

    Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

    Recruiting
    • Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 22, 2022

    Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

    Not yet recruiting
    • Neuroendocrine Tumors
    • Lutetium[177Lu] Oxodotreotide Injection
    • Octreotide LAR
    • Beijing, Beijing, China
    • +20 more
    Jul 25, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

    Recruiting
    • Gastric Cancer
    • +9 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Fludarabine + Cyclophosphamide combination
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    Neuroendocrine Tumors Trial in Seoul (Lanreotide autogel)

    Recruiting
    • Neuroendocrine Tumors
    • Lanreotide autogel
    • Seoul, Korea, Republic of
      Changhoon Yoo
    Jul 18, 2022

    Neuroendocrine Tumors Trial in Sherbrooke (68Ga-DOTA-TATE)

    Recruiting
    • Neuroendocrine Tumors
    • 68Ga-DOTA-TATE
    • Sherbrooke, Quebec, Canada
      CHUS
    Jul 18, 2022

    Neuroendocrine Tumors - Patient Reported Outcomes

    Enrolling by invitation
    • Neuroendocrine Tumors
    • +3 more
      • Gainesville, Florida
      • +13 more
      Jul 7, 2022

      Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Iowa City (Lutathera, Azedra)

      Not yet recruiting
      • Gastro-enteropancreatic Neuroendocrine Tumor
      • Neuroendocrine Tumors
      • Iowa City, Iowa
        Holden Comprehensive Cancer Center
      Jul 7, 2022

      Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

      Terminated
      • Neuroendocrine Tumors
      • +2 more
      • Denver, Colorado
      • +2 more
      Jul 5, 2022

      Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

      Recruiting
      • Neuroendocrine Tumors
      • Neuroendocrine Carcinoma
      • Göttingen, Lower Saxony, Germany
      • +5 more
      Jun 27, 2022

      Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NOTA-AE105, PET/CT)

      Completed
      • Neuroendocrine Tumors
      • One injection of 68Ga-NOTA-AE105
      • PET/CT
      • Copenhagen, Denmark
        Department of Clinical Physiology, Nuclear Medicine and PET, Rig
      Jun 28, 2022

      Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)

      Completed
      • Neuroendocrine Tumors
      • One injection of 68Ga-NODAGA-E[c(RGDyK)]2
      • PET/CT
      • Copenhagen, Denmark
        Department of Clinical Physiology, Nuclear Medicine and PET, Rig
      Jun 28, 2022

      HRQoL During PRRT in Patients With NETs

      Completed
      • Neuroendocrine Tumors
      • +2 more
        • (no location specified)
        Jun 16, 2022

        Neuroendocrine Tumors Trial in Belgium (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))

        Recruiting
        • Neuroendocrine Tumors
        • Liquid biopsies
        • Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
        • Bornem, Antwerp, Belgium
        • +7 more
        Jun 1, 2022

        Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

        Active, not recruiting
        • Cushing's Disease
        • +8 more
        • La Jolla, California
        • +93 more
        May 19, 2022

        Neuroendocrine Tumors Trial in Edmonton (18F-DOPA with furosemide)

        Not yet recruiting
        • Neuroendocrine Tumors
        • 18F-DOPA with furosemide
        • Edmonton, Alberta, Canada
          University of Alberta Hospital
        May 23, 2022